Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program
Go back to Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program(NASDAQ: OTIC) | Delayed: 0.08 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.08 | 52 Week High | $30.75 | |||
Open | $0.08 | 52 Week Low | $10.50 | |||
Day High | $0.08 | P/E | N/A | |||
Day Low | $0.08 | EPS | $0.00 | |||
Volume | 148 |